Article Summary: CAR-T, an experimental
treatment for cancer that supercharges the patient’s immune system by
genetically modifying immune cells, has had incredible results at high risks.
However, the risks of the treatment include death, though many of them are seen
as terminal without the treatment, and a new concern is that the cancer will
return. It is unknown if the results of the treatment are permanent or if the
cancer will return and, if it does, how quickly this will occur.
You can read MIT Technology Review's article on it here.
No comments:
Post a Comment